Dimetotiazine: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 1: Line 1:
__NOTOC__
{{Oxetoron}}
{{Oxetoron}}
{{CMG}}; {{AE}} {{PB}}
'''''For patient information, click [[Oxetoron (patient information)|here]]'''''.
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| Verifiedfields = changed
Line 58: Line 54:
| smiles = CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)S(=O)(=O)N(C)C)N(C)C
| smiles = CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)S(=O)(=O)N(C)C)N(C)C
}}
}}
__NOTOC__
{{CMG}}; {{AE}} {{PB}}


'''''For patient information, click [[Oxetoron (patient information)|here]]'''''.


==Overview==
==Overview==

Revision as of 19:17, 10 February 2014

Template:Oxetoron

Dimetotiazine
Clinical data
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • AU: <! -- A / B1 / B2 / B3 / C / D / X -->
  • US: <! -- A / B / C / D / X-- >
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • AU: <! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
  • CA: <! -- Schedule I, II, III, IV, V, VI, VII, VIII-- >
  • UK: <! -- GSL, P, POM, CD, or Class A, B, C-- >
  • US: <! -- OTC / Rx-only / Schedule I, II, III, IV, V-- >
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H25N3O2S2
Molar mass391.55 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Overview

Dimetotiazine (INN) is a phenothiazine. It is a serotonin antagonist and histamine antagonist.[1]


Dimetotiazine is also known as Dimetotiazine Dimétotiazine, Dimetotiazine Mesilate and Fonazine Mesylate.


Category

Antimigraine agent

Template:Antimigraine preparations


Template:WH

Template:WS

References

  1. Shimazawa M, Hara H, Watano T, Sukamoto T (August 1995). "Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats". Br. J. Pharmacol. 115 (8): 1359–68. PMC 1908864. PMID 8564192.


Template:Antimigraine preparations